Dilara Akhoundova

14PUBLICATIONS
34CO-AUTHORS
Molecular targetsMedical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 16, 2026
Reversing-or Rewiring-Lineage Plasticity? Lessons from EZH2 Loss in Prostate Cancer.

Phillip Thienger, Dilara Akhoundova, Mark A Rubin

|May 14, 2025
Prognostic Value of Post-Transplant MRD Negativity in Standard Versus High- and Ultra-High-Risk Multiple Myeloma Patients.

Lea Jasmin Kündgen, Dilara Akhoundova, Michele Hoffmann

|Apr 26, 2025
Adherence to Multidisciplinary Tumor Board Recommendations in Patients with Multiple Myeloma.

Valérie Gennheimer, Dilara Akhoundova, Michèle Hoffmann

|Apr 14, 2025
Impact of Venetoclax Treatment Schedule on Hematologic Recovery and Treatment Response in AML Patients Unfit for Intensive Chemotherapy.

Anja Schüpbach, Dilara Akhoundova, Ulrike Bacher

|Aug 10, 2024
Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation.

Selin G Ayçiçek, Dilara Akhoundova, Ulrike Bacher

|Jul 27, 2024
Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia.

Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel

Pageof 3

Frequent Collaborators

11 joint publications

Ulrike Bacher

11 joint publications

Thomas Pabst

6 joint publications

Katja Seipel

6 joint publications

Michael Daskalakis